Concepedia

Author

Joan Aebig

National Institute of Allergy and Infectious Diseases

Also Known As

J. Aebig, J.A. Aebig, Joan A. Aebig, Joan Aebig

25

Publications

1.4K

Citations

16

H-Index

42

Concepts

All Affiliations

National Institute of Allergy and Infectious DiseasesNational Institutes of HealthJohns Hopkins UniversityUniversity of BamakoUnited States Department of Agriculture
JA

About

Joan Aebig is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, malaria, and vaccination.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

468

2

Engineering

2

2

113

3

Biology

2

2

27

4

Public Health

1

1

20

5

Allergy

1

1

55

Joan Aebig

×

21

Publications

1.4K

Citations

16

H-Index

YearCitations

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Yimin Wu, Ruth D. Ellis, Donna Shaffer,

PLoS ONE

2008

450

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults

Kawsar R. Talaat, Ruth D. Ellis, Janet Hurd,

PLoS ONE

2016

135

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230

Nicholas J. MacDonald, Vu Nguyen, Richard L. Shimp,

Journal of Biological Chemistry

2016

107

Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle

Richard L. Shimp, Christopher G. Rowe, Karine Reiter,

Vaccine

2013

101

Impact on Malaria Parasite Multiplication Rates in Infected Volunteers of the Protein-in-Adjuvant Vaccine AMA1-C1/Alhydrogel+CPG 7909

C.J. Duncan, Susanne H. Sheehy, Katie Ewer,

PLoS ONE

2011

94

Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains

Raúl Herrera, Charles Anderson, Krishan Kumar,

Infection and Immunity

2015

67

Enhancement of functional antibody responses to AMA1-C1/Alhydrogel®, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide

Gregory Mullen, Birgitte Giersing, Olubunmi Ajose‐Popoola,

Vaccine

2006

55

Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria

Ruth D. Ellis, Yimin Wu, Laura B. Martin,

PLoS ONE

2012

55

Formulation of vaccines containing CpG oligonucleotides and alum

Joan Aebig, Gregory Mullen, G Dobrescu,

Journal of Immunological Methods

2007

54

VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to<i>Plasmodium falciparum</i>Placental Malaria

Justin Doritchamou, Raúl Herrera, Joan Aebig,

The Journal of Infectious Diseases

2016

38

Page 1